Skip to content

NANO-X IMAGING LTD (NNOX) Company Overview

Company Analysis

NANO-X IMAGING LTD NNOX

A comprehensive view of key metrics, scores, and financial health for NANO-X IMAGING LTD

Overview of Nano-X Imaging Ltd.

NNOX NGM
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Micro Cap
Nano-X Imaging Ltd. (NNOX), is a Micro Cap company, in the Medical Devices industry, last closed at $0.32, about 0.0% overvalued vs fair value, -91.7% 1Y return, ranked 823/1145 in sector.
Metrics Rev Growth 15.4% ROE -45.6% Gross Margin -98.2%
USD 0.32
-6.41%
(Delayed)
• Vol 90d: 136.0%
Market Cap
$22.46M
Enterprise Value
$-5.64M
Overall Score
Overall
Growth
Weak
Profitability
Weak
Health
Fair
Efficiency
Fair
Valuation
Fair
Growth
Weak
Profitability
Weak
Health
Fair
Efficiency
Fair
Valuation
Fair
Completeness: 82%
Confidence: 85%
Updated: Oct 24
Top Beats

Quick Facts

HQ Petah Tikva
Employees 165
Fiscal year Dec 31

Next Events

Earnings Nov 19 Estimated

Fair Value Snapshot

Bear Base Bull
$-1
$-1
$-1
Current: $0.32

Engine Room Money Flow™

Micro Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$13.0M
15.4%%
Gross Profit
-$12.8M
-20.5%%
Operating Income (GAAP)
-$78.2M
-37.9%%
EBITDA
-$49.0M
-8.9%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
-98.2%
Poor

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health healthy
Strong cash conversion with minimal leakage across profit-to-cash-to-value chain.
0
Active Leaks
0/0
Improving
0
High Impact
0
Critical
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating NANO-X IMAGING LTD's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
38
/100
Developing
Scores based on quantitative metrics and qualitative factors

Key strengths

  • Comfortable Interest Coverage Interest coverage quality is strong vs peers (score 0.68). Debt servicing capacity supports continued M&A optionality.
  • Improving FCF Trend FCF trend score is positive (score 0.84). Improving FCF margin signals compounding operational leverage.

Key risks

  • Below-Peer Gross Margins Gross margin quality lags peers (score 0.06). May indicate commodity-like product mix or distributor margin drag.
  • Weak Capital Return Profile Capital return quality is below peers (score 0.39). Low ROIC raises questions about M&A discipline and pipeline ROI.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Weak
10

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 83% Coverage
Trade-Off Triangle Visualization A ternary plot showing NNOX's balance between Growth (40.2%), Profitability (14.1%), and Safety (45.7%). Growth 40% Safety 46% Profitability 14%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

51th percentile vs peers
51
Key Signals
Rev Growth YoY 15.4% 67p Revenue CAGR 3Y 14.9% 66p EPS Growth YoY -26.9% 21p Asset Growth YoY -22.8% 13p
  • Equity/Assets in top 20% of peers (86.2%, 89th percentile)
  • Debt/Assets in top 20% of peers (4.8%, 81th percentile)
  • Conservative leverage compared to industry peers

No significant risks identified for this axis.

Profitability

18th percentile vs peers
18
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

58th percentile vs peers
59
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for NANO-X IMAGING LTD.

Loading scenario defaults...
Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$-1.03
- - -
- upside
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000